Get started
Work

Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer

Year: 2015
Type: article
Abstract: Meeting abstracts Prostate Cancer (PCa) is the third most common cancer type in the United States, with over 200,000 new cases projected to be diagnosed this year. In approximately 80% of PCa patients, tumor phenotype includes overexpression of prostate stem cell antigen, or PSCA. Furthermore, PSCA
DOI: 10.1186/2051-1426-3-s2-p115
Authors: Ethan Gerdts, Saul Priceman, Dileshni Tilakawardane, Anthony Park, Wen-Chung Chang, Sarah Wright, Christine E Brown, Stephen J Forman
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2214223737
FWCI: 0.13
Cites:
Cited by: 1
Related to: 10